INFLUENZA VIRUS VACCINE FOR HUMAN

Brand	Owner (click to sort)	Address	Description
FLU-IMUNE	AMERICAN CYANAMID COMPANY	Wayne NJ	INFLUENZA VIRUS VACCINE FOR HUMAN USE;FLU IMMUNE;
INFLUVAC	N.V. PHILIPS-DUPHAR	APOLLOLAAN 151 AMSTERDAM Netherlands	INFLUENZA VIRUS VACCINE FOR HUMAN USE;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

A human synthetic peptide-based influenza vaccine for intranasal administration comprises a mixture of flagella containing at least four epitopes of influenza virus reactive with human cells, each expressed individually in Salmonella flagellin, said influenza virus epitopes being selected from the group consisting of: (i) one B-cell hemagglutinin (HA) epitope; (ii) one T-helper hemagglutinin (HA) or nucleo-protein (NP) epitope that can bind to many HLA molecules; and (iii) at least two cytotoxic lymphocyte (CTL) nucleoprotein (NP) or matrix protein (M) epitopes that are restricted to the most prevalent HLA molecules in different human populations.